Shandong Jincheng Pharmaceutical and Chemical Co Ltd Asset Resilience Ratio
Shandong Jincheng Pharmaceutical and Chemical Co Ltd asset resilience ratio. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has an Asset Resilience Ratio of 3.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shandong Jincheng Pharmaceutical and Che defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2025–2025)
Asset resilience ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2025 to 2025. This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Asset Resilience Ratio has changed over time. Read 300233 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shandong Jincheng Pharmaceutical and Chemical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shandong Jincheng Pharmaceutical and Che balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥180.00 Million | 3.45% |
| Total Liquid Assets | CN¥180.00 Million | 3.45% |
Asset Resilience Insights
- Limited Liquidity: Shandong Jincheng Pharmaceutical and Chemical Co Ltd maintains only 3.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Jincheng Pharmaceutical and Chemical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
S&D Co. Ltd.
KQ:260970 |
Chemicals | 19.57% |
|
Suzhou Nanomicro Technology Co Ltd
SHG:688690 |
Chemicals | 4.37% |
|
Zhejiang Yongtai Technology Co Ltd
SHE:002326 |
Chemicals | 0.00% |
|
Solvac S.A.
BR:SOLV |
Chemicals | 0.00% |
|
Shanghai Pret Composites
SHE:002324 |
Chemicals | 0.27% |
|
HeBei Jinniu Chemical Industry Co Ltd
SHG:600722 |
Chemicals | 27.64% |
|
Shandong Yanggu Huatai Chemical Co Ltd
SHE:300121 |
Chemicals | 3.06% |
|
Yunnan Yunwei Co Ltd Class A
SHG:600725 |
Chemicals | 5.66% |
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Asset Resilience Ratio by Year (2025–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd asset resilience ratio by year from 2025 to 2025. The table below shows the annual Asset Resilience Ratio data for Shandong Jincheng Pharmaceutical and Chemical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.35% | CN¥70.00 Million ≈ $10.24 Million |
CN¥5.19 Billion ≈ $759.59 Million |
-- |
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.